Bayer gets FDA rebuke for drug production in Germany

FRANKFURT (Reuters) – Bayer said it had received a warning letter from the U.S. Food and Drug Administration over how it handled production of some drugs at its Leverkusen, Germany headquarters.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *